• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: MEDTRONIC IRELAND VENASEAL CLOSURE SYSTEM; AGENT, OCCLUDING, VASCULAR, PERMANENT

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

MEDTRONIC IRELAND VENASEAL CLOSURE SYSTEM; AGENT, OCCLUDING, VASCULAR, PERMANENT Back to Search Results
Model Number VS-403
Device Problem Biocompatibility (2886)
Patient Problem Local Reaction (2035)
Event Date 12/12/2023
Event Type  Injury  
Manufacturer Narrative
Medtronic submits this report to comply with fda regulations 21 cfr parts 4 and 803.Medtronic has made reasonable efforts to provide as much relevant information as is available to the company as of the submission date of this report.This report does not constitute an admission or a conclusion by fda, medtronic, or its employees that the device, medtronic, or its employee caused or contributed to the event described in the report.Any required fields that are unpopulated are blank because the information is currently unknown or unavailable.Medtronic will submit a supplemental report if additional relevant information becomes known.
 
Event Description
Physician used a venaseal closure system to treat a patient¿s great saphenous vein (gsv).The lumen was flushed prior to use.The ifu (instruction for use) was followed during preparation, procedure, post-procedure.A guidewire was used for the insertion of the catheter.Tumescent infiltration was not utilized.The procedure was completed and the vein was reported to have closed.Post op, there was an inflammatory reaction of venaseal and fragments of venaseal were removed surgically from the accessory veins.
 
Manufacturer Narrative
Image analysis 6 film images were returned for review.Film image 1: ¿image received of patient seemingly with a type of inflammatory reaction, consistent with the report event, lot number # of the device could not be confirmed based on the returned image.¿.Film image 2: ¿image received of patient seemingly with a type of inflammatory reaction, consistent with the report event, lot number # of the device could not be confirmed based on the returned image.¿.Film image 3: ¿image received of patient seemingly with a type of inflammatory reaction, consistent with the report event, lot number # of the device could not be confirmed based on the returned image.¿.Film image 4: ¿image received of patient seemingly with a type of inflammatory reaction, consistent with the report event, lot number # of the device could not be confirmed based on the returned image.¿.Film image 5: ¿image received of patient seemingly with a type of inflammatory reaction, consistent with the report event, lot number # of the device could not be confirmed based on the returned image.¿.Film image 6: ¿image received of patient seemingly with a type of inflammatory reaction.It is seemingly evident that a piece of adhesive is erupting from the skin of the patient, consistent with the report event, lot number # of the device could not be confirmed based on the returned image.¿.Medtronic submits this report to comply with fda regulations 21 cfr parts 4 and 803.Medtronic has made reasonable efforts to provide as much relevant information as is available to the company as of the submission date of this report.This report does not constitute an admission or a conclusion by fda, medtronic, or its employees that the device, medtronic, or its employee caused or contributed to the event described in the report.Any required fields that are unpopulated are blank because the information is currently unknown or unavailable.Medtronic will submit a supplemental report if additional relevant information becomes known.
 
Manufacturer Narrative
Additional information received reported that onset of symptoms occurred 5 days post procedure.The venaseal was explanted 2 months post index (b)(6) 2024.Anesthesia was used was local with sedation.There was no challenges or deviations related to location of catheter tip prior to initial delivery of adhesive.Compression was used.The issue is still present and posted surgery for complete exploration will be performed medtronic submits this report to comply with fda regulations 21 cfr parts 4 and 803.Medtronic has made reasonable efforts to provide as much relevant information as is available to the company as of the submission date of this report.This report does not constitute an admission or a conclusion by fda, medtronic, or its employees that the device, medtronic, or its employee caused or contributed to the event described in the report.Any required fields that are unpopulated are blank because the information is currently unknown or unavailable.Medtronic will submit a supplemental report if additional relevant information becomes known.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
VENASEAL CLOSURE SYSTEM
Type of Device
AGENT, OCCLUDING, VASCULAR, PERMANENT
Manufacturer (Section D)
MEDTRONIC IRELAND
parkmore business park west
galway
EI 
Manufacturer (Section G)
MEDTRONIC IRELAND
parkmore business park west
galway
EI  
Manufacturer Contact
alison sweeney
parkmore business park west
galway 
EI  
091708096
MDR Report Key18997917
MDR Text Key338877040
Report Number9612164-2024-01510
Device Sequence Number1
Product Code PJQ
Combination Product (y/n)N
Reporter Country CodeTC
PMA/PMN Number
P140018
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Foreign,Health Professional,Company Representative
Reporter Occupation Other
Type of Report Initial,Followup,Followup
Report Date 04/23/2024
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Expiration Date04/30/2024
Device Model NumberVS-403
Device Catalogue NumberVS-403
Device Lot Number67574
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? No
Initial Date Manufacturer Received Not provided
Initial Date FDA Received03/28/2024
Supplement Dates Manufacturer Received04/17/2024
04/22/2024
Supplement Dates FDA Received04/23/2024
04/23/2024
Date Device Manufactured04/08/2022
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Required Intervention;
-
-